Insight Molecular Diagnostics Total Long-Term Assets 2014-2025 | IMDX

Insight Molecular Diagnostics total long-term assets from 2014 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
Insight Molecular Diagnostics Annual Total Long-Term Assets
(Millions of US $)
2024 $23
2023 $64
2022 $75
2021 $120
2020 $46
2019 $17
2018 $1
2017 $2
2016 $2
2015 $2
2014 $2
2013 $3
Insight Molecular Diagnostics Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $24
2024-12-31 $23
2024-09-30 $65
2024-06-30 $65
2024-03-31 $64
2023-12-31 $64
2023-09-30 $65
2023-06-30 $67
2023-03-31 $67
2022-12-31 $75
2022-09-30 $121
2022-06-30 $122
2022-03-31 $122
2021-12-31 $120
2021-09-30 $121
2021-06-30 $127
2021-03-31 $66
2020-12-31 $46
2020-09-30 $46
2020-06-30 $45
2020-03-31 $41
2019-12-31 $17
2019-09-30 $12
2019-06-30 $1
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $1
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $2
2016-09-30 $2
2016-06-30 $2
2016-03-31 $2
2015-12-31 $2
2015-09-30
2015-06-30
2015-03-31
2014-12-31 $3
2013-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical Services $0.096B $0.002B
Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $144.179B 27.04
CVS Health (CVS) United States $86.198B 10.71
Elevance Health (ELV) United States $84.314B 10.88
Cencora (COR) United States $57.484B 20.00
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.963B 0.00
Labcorp Holdings (LH) United States $21.509B 17.45
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.205B 0.00
Solventum (SOLV) United States $12.912B 13.67
CochLear (CHEOY) Australia $12.870B 0.00
ICON (ICLR) Ireland $11.851B 11.02
Revvity (RVTY) United States $11.644B 20.04
Viatris (VTRS) United States $10.704B 3.68
Avantor (AVTR) United States $9.363B 13.60
HealthEquity (HQY) United States $9.068B 39.72
Medpace Holdings (MEDP) United States $8.818B 23.42
Sonic Healthcare (SKHHY) Australia $8.465B 0.00
Charles River Laboratories (CRL) United States $7.445B 14.59
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.269B 25.15
BrightSpring Health Services (BTSG) United States $4.058B 37.23
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.781B 36.17
Alignment Healthcare (ALHC) United States $2.722B 0.00
Concentras Parent (CON) United States $2.652B 15.33
Organon (OGN) United States $2.594B 2.76
GeneDx Holdings (WGS) United States $2.556B 98.45
PACS (PACS) United States $1.958B 0.00
Ardent Health (ARDT) United States $1.904B 8.12
Progyny (PGNY) United States $1.840B 40.49
Premier (PINC) United States $1.796B 13.63
GoodRx Holdings (GDRX) United States $1.761B 35.21
Teladoc Health (TDOC) United States $1.412B 0.00
Establishment Labs Holdings (ESTA) $1.181B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
CareDx (CDNA) United States $1.074B 16.77
Agilon Health (AGL) United States $0.956B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.658B 9.96
LifeMD (LFMD) United States $0.615B 0.00
Embecta (EMBC) United States $0.542B 3.65
InnovAge Holding (INNV) United States $0.532B 0.00
Enhabit (EHAB) United States $0.482B 39.62
Auna S.A (AUNA) Luxembourg $0.470B 10.58
SBC Medicals (SBC) United States $0.464B 0.00
Omada Health (OMDA) $0.460B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
Performant Healthcare (PHLT) United States $0.312B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.249B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
So-Young (SY) China $0.209B 0.00
Oncology Institute (TOI) United States $0.200B 0.00
DocGo (DCGO) United States $0.172B 28.17
Pheton Holdings (PTHL) China $0.115B 0.00
KindlyMD (NAKA) United States $0.089B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
ModivCare (MODV) United States $0.051B 0.00
Biodesix (BDSX) United States $0.041B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00